Angion_2IN-02.jpg
Angion Biomedica Corp. Announces Pricing of Initial Public Offering of Common Stock and Concurrent Private Placement
February 05, 2021 08:30 ET | Angion Biomedica Corp.
UNIONDALE, N.Y., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development and commercialization...
ISHLT Elects Lara Danziger-Isakov President-Elect Addison, Texas, May 20, 2020 (GLOBE NEWSWIRE) -- Lara Danziger-Isakov MD, MPH, Director of Immunocompromised Host Infectious Disease at the Cincinnati Children’s Hospital Medical Center in...
Joseph G. Rogers, MD, elected president of ISHLT Addison, Texas, May 19, 2020 (GLOBE NEWSWIRE) -- Joseph G. Rogers, MD, cardiologist, Professor of Medicine at the Duke University School of Medicine and Chief Medical Officer at the Duke University...
CTA_Logo_rgb.jpg
The Olympic Games you’ve never heard of come to Canada this month
February 12, 2020 07:00 ET | Canadian Transplant Association
WHITE ROCK, British Columbia, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The only worldwide athletic competition for organ transplant recipients will get underway in less than three weeks in Banff, Alta.  ...
The Best Thanksgiving
November 26, 2019 17:59 ET | The Children's Inn at NIH
Bethesda, Maryland, Nov. 26, 2019 (GLOBE NEWSWIRE) -- One Texas family has lots to be thankful for this Thanksgiving. Their daughter, now 13, is doing well after undergoing a bone marrow...
UNIVERSITY HOSPITAL FOUNDATION FUND RECIPIENTS POISED TO REVOLUTIONIZE ORGAN TRANSPLANTS
November 07, 2019 13:00 ET | University Hospital Foundation
Edmonton, Alberta, Nov. 07, 2019 (GLOBE NEWSWIRE) -- The University Hospital Foundation (UHF) and Alberta Health Services are celebrating 12 successful lung transplants using the Ex-Vivo Organ...
Researchers develop method for early detection of common post-transplant cancer Orlando, Fla., April 03, 2019 (GLOBE NEWSWIRE) -- With suppressed immune systems, people who receive organ transplants have a higher risk for getting cancer. But new research has identified a way to...
Equillium Logo.png
Equillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host Disease
February 07, 2019 08:08 ET | Equillium
LA JOLLA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the...
Equillium_Transparent-300px.png
Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
December 19, 2018 08:06 ET | Small Logo
LA JOLLA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the...
Great News for Living Organ Donors: U.S. Department of Labor Says Organ Donors are Protected Under FMLA
August 29, 2018 12:24 ET | American Kidney Fund
ROCKVILLE, Md., Aug. 29, 2018 (GLOBE NEWSWIRE) -- The American Kidney Fund today commended a new opinion letter from the U.S. Department of Labor (DOL) that protects the job security of living organ...